β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (466) π οΈ Industry Q&A (100) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
| Date accepted | Link | Final link |
|---|---|---|
| 2025-04-29 14:26:32 | SCHEDULE 13G/A | SCHEDULE 13G/A final |
| 2025-04-17 10:12:37 | DEFA14A | DEFA14A final |
| 2025-04-17 10:11:57 | DEF 14A | DEF 14A final |
| 2025-03-31 17:34:29 | 4 | 4 final |
| 2025-03-31 17:32:21 | 4 | 4 final |
| 2025-03-31 17:30:28 | ***** | ***** |
| 2025-03-31 17:29:02 | ***** | ***** |
| 2025-03-31 17:25:57 | ***** | ***** |
| 2025-03-31 17:23:17 | ***** | ***** |
| 2025-03-31 17:18:53 | ***** | ***** |
| 2025-03-31 17:17:17 | ***** | ***** |
| 2025-03-31 17:14:07 | ***** | ***** |
| 2025-03-31 17:09:50 | ***** | ***** |
| 2025-03-21 16:12:46 | ***** | ***** |
| 2025-03-21 12:09:04 | ***** | ***** |
π Explore more SEC filings for LeMaitre Vascular!
Sign up for free or log inπ Join us and grab your copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks"